EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Nephrolithiasis: A Comprehensive Review of Pathophysiology, Clinical Presentation, and Management

S. B Bothra, Shahajan Shabbir Baig, Barrawaz Aateka Yahya

Journal of Innovations in Pharmaceutical and Biological Sciences · 2026 · 13 (01) · 83-95

DOI: 10.56511/jipbs.2026.13110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Innovations in Pharmaceutical and Biological Sciences, 2026. Verfasst von S. B Bothra und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephrolithiasis affects approximately 12% of the global population with increasing prevalence linked to obesity, metabolic syndrome, and dietary factors. Calcium oxalate and calcium phosphate stones comprise 70–80% of cases, followed by uric acid (10–15%), struvite (10–15%), and cystine stones (

Zitieren

APA

Bothra, S. B., Baig, S. S., & Yahya, B. A. (2026). Nephrolithiasis: A Comprehensive Review of Pathophysiology, Clinical Presentation, and Management. Journal of Innovations in Pharmaceutical and Biological Sciences, 13(01), 83-95. https://doi.org/10.56511/jipbs.2026.13110

Vancouver

Bothra SB, Baig SS, Yahya BA. Nephrolithiasis: A Comprehensive Review of Pathophysiology, Clinical Presentation, and Management. Journal of Innovations in Pharmaceutical and Biological Sciences. 2026;13(01):83-95. doi:10.56511/jipbs.2026.13110

BibTeX
@article{Bothra2026,
  author = {Bothra, S. B and Baig, Shahajan Shabbir and Yahya, Barrawaz Aateka},
  title = {Nephrolithiasis: A Comprehensive Review of Pathophysiology, Clinical Presentation, and Management},
  journal = {Journal of Innovations in Pharmaceutical and Biological Sciences},
  year = {2026},
  volume = {13},
  number = {01},
  pages = {83--95},
  doi = {10.56511/jipbs.2026.13110}
}
Kostenlos starten →